PFO
LLY icon

Pathstone Family Office’s Eli Lilly LLY Stock Holding History

Pathstone Family Office’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$26.2M Buy
48,177
+26,406
+121% +$13.6M 0.2% 79
2023
Q2 		$10.7M Buy
21,771
+1,443
+7% +$605K 0.15% 102
2023
Q1 		$6.59M Sell
20,328
-44,226
-69% -$14.9M 0.11% 130
2022
Q4 		$15M Buy
64,554
+17,082
+36% +$6.06M 0.13% 124
2022
Q3 		$15.8M Buy
47,472
+33,431
+238% +$10.6M 0.14% 99
2022
Q2 		$4.55M Buy
14,041
+3,801
+37% +$1.14M 0.1% 113
2022
Q1 		$3.11M Sell
10,240
-353
-3% -$90.8K 0.07% 133
2021
Q4 		$2.93M Buy
10,593
+709
+7% +$180K 0.07% 138
2021
Q3 		$2.28M Buy
9,884
+5,320
+117% +$1.31M 0.07% 146
2021
Q2 		$1.05M Buy
4,564
+437
+11% +$87.8K 0.03% 261
2021
Q1 		$772K Buy
4,127
+1,121
+37% +$219K 0.03% 260
2020
Q4 		$508K Buy
3,006
+308
+11% +$46K 0.02% 176
2020
Q3 		$399K Hold
2,698
– – 0.04% 132
2020
Q2 		$443K Hold
2,698
– – 0.05% 112
2020
Q1 		$374K Buy
2,698
+5
+0.2% +$687 0.05% 119
2019
Q4 		$3.54M Buy
2,693
+5
+0.2% +$580 0.04% 115
2019
Q3 		$301K Sell
2,688
-3,950
-60% -$440K 0.04% 119
2019
Q2 		$734K Sell
6,638
-48
-0.7% -$5.65K 0.09% 101
2019
Q1 		$868K Buy
6,686
+4,102
+159% +$499K 0.11% 82
2018
Q4 		$299K Buy
+2,584
New +$289K 0.09% 71
2018
Q2 		– Sell
-30
Closed -$2K – 250
2018
Q1 		$2K Buy
30
+1
+3% +$81 ﹤0.01% 330
2017
Q4 		$2K Buy
+29
New +$2.47K ﹤0.01% 133
2017
Q3 		– Sell
-29
Closed -$2K – 264
2017
Q2 		$2K Hold
29
– – ﹤0.01% 359
2017
Q1 		$2K Buy
+29
New +$2.32K ﹤0.01% 393
2013
Q3 		– Sell
-500
Closed -$25K – 381
2013
Q2 		$25K Buy
+500
New +$27.2K 0.03% 174

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Pathstone Family Office's LLY Position: Q3 2023 in Review

Pathstone Family Office increased its Eli Lilly (LLY) stake by 121% in Q3 2023, buying an estimated $13.6M and bringing the position to 48,177 shares worth $26.2M. The position accounts for 0.2% of the portfolio, ranked #79.

Pathstone Family Office first reported a position in LLY in Q2 2013 and has held it in 25 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Pathstone Family Office held 48,177 shares of Eli Lilly worth $26.2M as of Q3 2023.
  • Pathstone Family Office bought 26,406 Eli Lilly shares in Q3 2023, an estimated $13.6M.
  • Eli Lilly made up 0.2% of Pathstone Family Office's portfolio in Q3 2023, its #79 holding.
  • Pathstone Family Office first reported a position in Eli Lilly in Q2 2013 and has held it in 25 quarters since.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.